Literature DB >> 16133934

Giant cells: contradiction to two-hit model of tuber formation?

Jaroslaw Jozwiak1, Sergiusz Jozwiak.   

Abstract

1. Tuberous sclerosis (TSC) is an autosomal dominant disease characterized by the formation of hamartomatous lesions in many organs, including brain, heart or kidneys. It has been found that TSC is caused by the mutation in one of two tumor suppressor genes: TSC1 or TSC2, encoding hamartin and tuberin, respectively. 2. According to Knudson's two-hit model of tumorigenesis, second-hit mutation and resulting loss of heterozygosity (LOH) of a tumor suppressor gene is necessary for tumor formation. In fact, LOH is commonly found in several types of hamartomas formed in the process of tuberous sclerosis, but, interestingly, not in brain lesions, containing characteristic giant cells. 3. In the present paper we review literature covering origination of giant cells and present several hypotheses explaining why in spite of the presence of hamartin and tuberin, brain lesions form in TSC patients.

Entities:  

Mesh:

Year:  2005        PMID: 16133934     DOI: 10.1007/s10571-005-4932-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  66 in total

1.  Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study.

Authors:  S H Park; S H Pepkowitz; C Kerfoot; M J De Rosa; V Poukens; R Wienecke; J E DeClue; H V Vinters
Journal:  Acta Neuropathol       Date:  1997-08       Impact factor: 17.088

2.  Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues.

Authors:  M Menchine; J K Emelin; P S Mischel; T A Haag; M G Norman; S H Pepkowitz; C T Welsh; J J Townsend; H V Vinters
Journal:  Mod Pathol       Date:  1996-11       Impact factor: 7.842

3.  Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis.

Authors:  S Lantuejoul; G Ferretti; A Negoescu; B Parent; E Brambilla
Journal:  Histopathology       Date:  1997-06       Impact factor: 5.087

Review 4.  Review and hypotheses: somatic mosaicism: observations related to clinical genetics.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

5.  The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.

Authors:  R F Lamb; C Roy; T J Diefenbach; H V Vinters; M W Johnson; D G Jay; A Hall
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

6.  Cortical tubers without other stigmata of tuberous sclerosis: imaging and pathological findings.

Authors:  A Yagishita; N Arai
Journal:  Neuroradiology       Date:  1999-06       Impact factor: 2.804

7.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

8.  Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.

Authors:  H K Wolf; S Normann; A J Green; I von Bakel; I Blümcke; T Pietsch; O D Wiestler; A von Deimling
Journal:  Acta Neuropathol       Date:  1997-01       Impact factor: 17.088

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry on the CNS.

Authors:  T M Chou; S M Chou
Journal:  Clin Neuropathol       Date:  1989 Jan-Feb       Impact factor: 1.368

View more
  5 in total

Review 1.  Epilepsy related to developmental tumors and malformations of cortical development.

Authors:  Eleonora Aronica; Peter B Crino
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 2.  The growing role of mTOR in neuronal development and plasticity.

Authors:  Jacek Jaworski; Morgan Sheng
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

Review 3.  Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.

Authors:  Emmett V Schmidt; Michael J Ravitz; Li Chen; Mary Lynch
Journal:  Cell Cycle       Date:  2009-05-18       Impact factor: 4.534

Review 4.  Hamartin and tuberin modulate gene transcription via beta-catenin.

Authors:  Jaroslaw Jozwiak; Pawel Wlodarski
Journal:  J Neurooncol       Date:  2006-03-22       Impact factor: 4.130

5.  Brain tumor formation in tuberous sclerosis depends on Erk activation.

Authors:  Jaroslaw Jozwiak; Wieslawa Grajkowska; Katarzyna Kotulska; Sergiusz Jozwiak; Wojciech Zalewski; Agnieszka Zajaczkowska; Marcin Roszkowski; Artur Slupianek; Pawel Wlodarski
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.